CAR-T cell immuno-oncology therapy firms
For reference only. Not investment advice. You are solely responsible for your investment decisions.
7/6 · Real-time
Of 15 CAR-T stocks tracked today, 4 are up and 10 down (avg -1.99%), an overall weak tone. The top gainer is 안트로젠 (+2.83%), while 에이비엘바이오 (-6.14%) lags the group.
Based on live prices and updated periodically. Not investment advice.
CAR-T cell immuno-oncology therapy firms Switch between Korean and US stock tabs below to see live prices.
Based on publicly known business structure. Not investment advice.
CAR-T Stocks is a key investment theme in 2026. CAR-T cell immuno-oncology therapy firms PFlow tracks 18 related stocks — 16 Korean and 2 US — with live prices in one view.
There are 18 stocks related to CAR-T Stocks — 16 Korean and 2 US stocks. Check live prices and performance in the tabs above.
PFlow's CAR-T Stocks page (pflow.app/en/theme/car-t) shows Korean and US leading stocks with live price changes. Click any stock to view detailed data.
Korean CAR-T Stocks stocks are 16 KOSPI/KOSDAQ-listed companies, while US CAR-T Stocks stocks are 2 NASDAQ/NYSE-listed companies. Comparing both helps gauge global demand trends and valuation differences.
There are 18 companies related to CAR-T — 16 Korean and 2 US. Check their live prices and leading stocks in the list above.
※ This page provides price information for companies with business connections to the listed theme. It is not a recommendation to buy or sell any specific stock. Investors are solely responsible for their investment decisions. Please conduct thorough research before investing.